Smith J N, Ayrton A D, Chown J, Lewis D F, Ioannides C
Department of Biochemistry, University of Surrey, Guildford, United Kingdom.
J Biochem Toxicol. 1990 Spring;5(1):9-12. doi: 10.1002/jbt.2570050103.
The ability of feprazone to induce the hepatic microsomal mixed-function oxidases was investigated in the rat, with emphasis being placed on the nature of the cytochrome P-450 family induced. Treatment with feprazone enhanced the p-hydroxylation of aniline and the dealkylations of benzphetamine and pentoxyresorufin but had no effect on the O-deethylation of ethoxyresorufin. The same treatment had no major effect on total cytochrome P-450 levels but increased the spectral interaction of metyrapone with reduced cytochrome P-450. Immunoblots employing monospecific polyclonal antibodies revealed that feprazone induces the apoprotein levels of the P450 II B, but not of the P450 I, family. It is concluded that feprazone is an inducer of the rat hepatic mixed-function oxidase system showing selectivity toward the P450 II B family.
研究了非普拉宗在大鼠体内诱导肝微粒体混合功能氧化酶的能力,重点关注所诱导的细胞色素P - 450家族的性质。用非普拉宗处理可增强苯胺的对羟基化以及苄非他明和戊氧基试卤灵的脱烷基作用,但对乙氧基试卤灵的O - 脱乙基作用无影响。相同处理对细胞色素P - 450的总水平无主要影响,但增加了甲吡酮与还原型细胞色素P - 450的光谱相互作用。使用单特异性多克隆抗体的免疫印迹显示,非普拉宗诱导P450 II B家族的载脂蛋白水平,但不诱导P450 I家族的载脂蛋白水平。结论是非普拉宗是大鼠肝混合功能氧化酶系统的诱导剂,对P450 II B家族具有选择性。